Monopar Therapeutics (MNPR) › Total LiabilitiesMonopar Therapeutics (MNPR) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2016: $64.5K2017: $311.9K2018: $399.6K2019: $724.2K2020: $1.18M2021: $1.58M2022: $3.14M2023: $1.76M2024: $5.25M2025: $2.89M$2.89M2016Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$2.89M-45.0%2024$5.25M+199.0%2023$1.76M-44.0%2022$3.14M+98.5%2021$1.58M+34.3%2020$1.18M+62.5%2019$724.2K+81.2%2018$399.6K+28.1%2017$311.9K+383.4%2016$64.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share